Sylvain Cardinaud

Creteil, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers.

CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers.

Journal: Scientific reports
Published: January 06, 2026

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

Journal: EBioMedicine
Published: September 10, 2025

Antibody-mediated targeting of SOSIP HIV-1 Env to skin Langerhans cells potentiates humoral responses.

Antibody-mediated targeting of SOSIP HIV-1 Env to skin Langerhans cells potentiates humoral responses.

Journal: EBioMedicine
Published: August 02, 2025

Author Correction: Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.

Author Correction: Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.

Journal: Nature communications
Published: March 06, 2025

IgA-dependent cell phagocytosis of HIV-infected cells elicits cross-presentation to CD8+T cells and immune memory in effector monocytes.

IgA-dependent cell phagocytosis of HIV-infected cells elicits cross-presentation to CD8+T cells and immune memory in effector monocytes.

Journal: Mucosal immunology
Published: February 19, 2025

Targeting Langerhans cells via skin delivery of HIV Envelope enhances the antibody response to vaccination.

Targeting Langerhans cells via skin delivery of HIV Envelope enhances the antibody response to vaccination.

Journal: NPJ vaccines
Published: December 25, 2024

Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection.

Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection.

Journal: Antiviral research
Published: December 03, 2024

Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06).

Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06).

Journal: EClinicalMedicine
Published: July 08, 2024

Vaccine Efficacy, Impact, Hesitancy, and Acceptance: Trends for Public Health.

Vaccine Efficacy, Impact, Hesitancy, and Acceptance: Trends for Public Health.

Journal: Vaccines
Published: March 25, 2024

A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease.

A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease.

Journal: Cell reports. Medicine
Published: October 06, 2023

Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells.

Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells.

Journal: EBioMedicine
Published: September 10, 2023

Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.

Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.

Journal: Nature communications
Published: August 11, 2023
Showing 1-12 of 31

Last Updated: 09/26/2026